Interested in purchasing Omnigen?

Register your interest

Click Here

Have a question about our products or pipelines?

Speak to our team of experts

Click Here

Saving sight through an innovative vision

NuVision® was established to commercialise high quality and affordable regenerative medicine delivered through innovative approaches to tissue preservation and application.

Introducing Omnigen®

Omnigen is a unique ‘off the shelf’, easily transportable biological matrix that can be used as an effective wound dressing. Longterm storage at room temperature allows use as effective wound dressing to treat ocular surface and other indications.

A message from our CEO

With a strong, experienced team, supported by a history of innovative research, we have the products that have the potential to revolutionise wound care worldwide.  Having over 15 year’s expertise in ocular regenerative medicine, and personally evolving Omnigen from concept to commercialisation, I believe NuVision has endless potential for growth.

Andrew Hopkinson

Founder and CEO, NuVision Biotherapies

Introducing Tereo™

The Tereo process is a patented and proprietary manufacturing process which renders fresh amniotic membrane and its associated wound healing properties, dry and stable. This stable biological matrix can be distributed and stored at room temperature. Tereo processed amniotic membrane (Omnigen) can be used directly from the packaging, is easy to cut and handle and will rehydrate in vivo from moisture at the wound site within 2 minutes.

Latest News

NuVision step into Europe

NuVision Biotherapies Limited, a UK-based regenerative medicine company, and University of Tampere, Regea Cell and Tissue Centre, a Finnish clinical tissue bank, have announced the signing of a strategic partnership to distribute the sight saving and wound care... read more

Connect with Us